At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 60 enrolled
Drug / intervention
PRP injection +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Is There Any Advantage of PRP Over Autologous Blood Injection in the Treatment of Chronic Plantar Fasciitis? A Prospective Randomized Double Blinded Study
In Brief
A Phase 3 clinical trial evaluating PRP injection and ABI injection for Plantar Fascitis. Completed, enrolled 60 participants across 1 site.
Detailed Summary
To explore effects of Autologous Blood Injection versus Platelet Rich plasma injection for treatment of chronic plantar fasciitis
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPlantar Fascitis
CountriesTurkey (Türkiye)
Collaborators--
Timeline
Phase 3CompletedFinished
2020202120222023202420252026
Enrollment StartMar 2020
Primary CompletionOct 2020
Study CompletionJan 2022
First PostedFeb 2022
TodayJul 2026
First PostedFeb 15, 2022
Enrollment StartMar 1, 2020
Primary CompletionOct 30, 2020
Study CompletionJan 15, 2022
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 4.4 years ago
Interventions
PRP injectionbiological
Plantar fascia injection therapy with PRP
ABI injectionbiological
ABI injection